Blank

Aliskiren nejm

Common Questions and Answers about Aliskiren nejm

tekturna

Avatar f tn Found an article from the New England Journal of medicine NEJM first hit in my google search “Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection“ Apparently this condition is on the spectrum of known extrahepatic conditions that are associated with hep c infection in some patients. There is an article titled “Extrahepatic manifestations of chronic hepatitis C virus infection” on ncbi.nlm.nih.
Avatar n tn The valtrex and reduction in transmission study in the NEJM jan 1, 2004 is a terrific article to read. You can register to read it fo rfree on their website.
976897 tn?1379167602 http://healthland.time.com/2013/01/02/being-overweight-is-linked-to-lower-risk-of-mortality/ Probably the key lies somewhere in the finding that 'overweight' people--but not the truly obese--are at less risk. My own suspicion is that the pleasantly plump are simply better nourished in general, giving them a natural edge in terms of survivability when illness or disaster strike.
Avatar n tn My infant daughter has this too. I read on NEJM that bath/hair/body products containing lavender or tea tree oil/fragrance can cause the breast buds as they have estrogenic effect. I have eliminated these recently. I would suggest you do so too.
572651 tn?1530999357 But they also pointed out that Fumaderm, as well as a compounded product known as Psorinovo -- involved in one of the NEJM reports -- contained other active ingredients, and the patients had additional "significant confounding factors" as well" "One patient in the Netherlands and another in Germany developed PML after several years of treatment with European formulations of the drug, long available as psoriasis treatments, according to two separate case reports in the April
Avatar f tn You can read the whole valtrex and reduction in transmission study for free on the NEJM website ( jan 1, 2004 issue ). Just register there and you can read it. Yes, 2/3's or so of the folks who transmitted the virus during the study were not remembering to take their medication at least 80% of days. Remembering to take it daily ups the odds of not transmitting to a partner even more. I've never transmitted the virus to a partner since I"ve been on daily suppressive therapy.
10947 tn?1281404252 Often these references are hyperlinked to the original source (say the pdf file of a nejm paper). Will you allow these hyperlinks? Your current TOS forbids links and hyperlinks.
Avatar f tn The HALT-C patients in that NEJM article were enrolled between Aug '00 and Aug '04 and treated for 3.5 years. I believe that article publishes data originally reported at AASLD'07 Here's a summary of an abstract from EASL'08 reporting data collected in the COPILOT study http://www.hcvadvocate.org/news/reports/EASL_2008/Advocate%20EASL%202008%20Coverage.
Avatar n tn This really doesn't sound like it's herpes to be honest. He should get a herpes lesion culture done though if it's been more than a few days the chances of it being negative are pretty high. The only other option is to repeat his blood test in a few months. The valtrex and transmission study published in the NEJM in 2004 showed that in the partners who's hsv2+ partners were on suppressive therapy contracted hsv2, they were more likely to have asymptomatic infections.
Avatar n tn Ok so approx 4 weeks ago had unprotected oral sex with two women from backpages. Received oral twice and received riming once during. Ok so freaking out right now. Became violently sick Friday night vomiting lasted most the night. Still feeling nausus slightly. Occational direah. Somewhat ache, no fever or rash at this point. Urin is darker then normal. My major concern is had SE. With my wife 5 days post. Worried about her and the possibilty of transmission to her if I was exposed.
190885 tn?1333025891 Mikesimon gave you the statistics with percentage for rash. I can tell you my personal experience, and what I've heard from others. It seems that people who have trouble with rashes anyway (fair skin) tend to get the worst rashes on Tela. I've never had problems with skin rashes in the past. While on the Tela for the first 8 wks of tx, I developed a rash which was dry, itchy, burning and sandpapery, which began at 6 or 7 wks. It was mostly on trunk and arms and thighs.
Avatar m tn I'm sure that anyone who has obsessed over a possible GHSV infection is familiar with the NEJM article (published in 1999) that gives data on conversion times. I'm fairly certain that that article is what Anna Wald and Terri Warren are quoting when they go forward with their own guidance around when someone should expect to build detectable antibodies.
Avatar f tn UVL also deactivates many viruses with the assistance of the extra Vitamin D it produces within the epidermis tissue according to research discovered in the NEJM and JAMA archives. As soon as I began this regimen along with the carrot juice, (riboflavinoids - quercetin contained within and it's highly alkalizing - although wheatgrass juice would be preferred but wasn't handy), she immediately began to turn around - within 30 minutes.
Avatar n tn Why are antibodies to HSV2 so prevalent in the western world given the results of several studies (e.g. NEJM, Jan 2004 – suggesting an approximate 5% annual transmission between discordant couples not engaging in sex during ‘outbreaks’? 3. What is your opinion on screening asymptomatic people? 4.
Avatar m tn that number comes from the valtrex and reduction in transmission study done and published in the NEJM a few years back ( know it was the jan 1 issue but can't recall the date at this point ). It's the same stat quoted in the free herpes handbook by Terri Warren, our herpes expert here on medhelp too.
Avatar m tn Another option is for her to print out the NEJM article on valtrex reducing transmission to a partner and take it to her doctor. As someone who has lived with genital herpes for most of her life, I know personally how the peace of mind of being on it can help you have a "normal" sex life as well as protect a partner! Knowing you are actively doing something to protect a partner really helps even if you aren't having noticeable recurrences.
Avatar n tn One report that has all but convinced me is a study, reported by the New England Journal of Medicine (NEJM) entitled "Quality of Life After Radical Prostatectomy or Watchful Waiting" Volume 347:790-796, September 12,2002 Number 11 http://content.nejm.org/cgi/content/full/347/11/790 The entire article can be summed up in the last 2 paragraphs.
Avatar f tn m not sure where your quote comes from, but I did check out the study from NEJM that it references. The NEJM study in no way says that up to a quarter of people with Hashi's spontaneously return to normal. In fact, in the study, only 9% of people with Hashi's even had positive thyroid stimulating blocking antibodies, and of that 9%, less than half saw their blocking antibodies go into remission. I would have to wonder where all those people whose TRab went into remission are.
415266 tn?1202635558 According to Roche 2004 trial ( posted in NEJM) 48 week of pegasys resulted in 42% of HBV DNA<20000 copies/ml but it maintained in only 30% after 3 years f/u ( P Marcellin) A pilot trial ( AM J Gastroenterl 2007;102:2718-2723) pointed out better results of 60 weeks pegasys ( 69% HBV DNA<20000 after 24 weeks off-pegasys periods). It also mentioned greater supress of HBsAg in those who succeed.
Avatar f tn http://www.nejm.org/doi/full/10.1056/NEJMp0904768 excerpt: "Before 1994, herbal products were considered food additives, and their manufacturers were required to show proof of safety before marketing them. Since the passage of the DSHEA, dietary supplements are presumed to be safe and can be marketed with very little oversight. The DSHEA presents serious obstacles to the FDA’s ability to detect and eliminate contaminated supplements.
5979406 tn?1378064701 This new study is one of several testing new hepatitis C drugs that were published April 23 in an online edition of NEJM. The journal publication coincides with the International Liver Congress 2013 in Amsterdam, the Netherlands, where the results also will be presented. "The new sofosbuvir therapy offers a much-needed alternative to standard therapy with interferon, which can cause significant side effects for hepatitis C patients," says the study's lead investigator, Dr.